Ocular Therapeutix grants inducement awards to new hires, including options priced at $8.4 per share

Ocular Therapeutix granted inducement equity awards to eight newly hired non-executive employees under its 2019 Inducement Stock Incentive Plan.

The grants, effective Aug. 3, 2026, cover stock options for 53,975 shares with an exercise price of $8.4 per share, a 10-year term, and vesting over four years.

Restricted stock units cover 17,450 shares and vest over three years in equal annual installments.